of this proposed rule), we have determined that adjusting certain Shared Savings Program calculations to remove payment amounts for selected codes, in the event we determine SAHS billing activity occurs in CY 2024 or subsequent calendar years, from the calculation of performance year expenditures, updates to the historical benchmark, and ACO participants' Medicare FFS revenue used for multiple purposes across the Shared Savings Program, meets the requirements for use of our authority under section 1899(i)(3) of the Act when incorporated into the existing other payment model we have established pursuant to that section
Flavorful little nicotine delivery systems
Despite the fact that no oral nicotine pouch is an FDA-approved cessation treatment, products like Zyn continue to market themselves as a way to stop smoking, through promotions like the Zyn 10 Challenge, [21] alongside their marketing of the product a recreational product
We propose to adjust an ACO's historical benchmark for use in reaching an initial determination of financial performance for a performance year, in cases where an ACO has a benchmark year that corresponds to a performance year for which we issued a revised initial determination